BUSINESS
Teijin, Kyorin Expected to Grow thru “Win-Win” Relationship: Teijin Pharma Pres.
A strategic partnership forged earlier this month between Teijin Ltd. and Kyorin Holdings is hoped to spur growth of both parties, Hiroshi Uno, president of Teijin Pharma, said in a recent interview with Jiho. On April 2, Teijin acquired 10%…
To read the full story
Related Article
BUSINESS
- Tanabe Unveils PIII Data for EPP/XLP Therapy, Backing Filing Plans
March 31, 2026
- Meiji Pharma Invests in Centivax to Support Vaccine R&D
March 31, 2026
- Takeda’s Zasocitinib Logs Positive Results in Global PIII Psoriasis Trials
March 31, 2026
- Ferring, Nippon Kayaku to Co-Promote Bladder Cancer Gene Therapy
March 31, 2026
- Mochida to Acquire Urece from Fuji Yakuhin for 13.5 Billion Yen
March 31, 2026
Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing
Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…





